title: Relationships among nitric oxide metabolites and pulses of a PGF2α metabolite during and after luteolysis in mares.
abstract: Hourly circulating concentrations of a PGF2α metabolite (PGFM), progesterone (P4), and LH were obtained from a reported project, and concentrations of nitric oxide (NO) metabolites (NOMs; nitrates and nitrites) were determined in eight mares. Unlike the reported project, hormone concentrations were normalized to the peak of the first PGFM pulse of luteolysis (early luteolysis), second PGFM pulse (late luteolysis), and a pulse after luteolysis. The duration of luteolysis was 23.1 ± 1.0 hours, and the peak of the first and second PGFM pulses occurred 6.5 ± 0.9 and 14.8 ± 0.8 hours after the beginning of luteolysis. Concentration of P4 decreased progressively within and between the PGFM pulses Changes were not detected in LH concentration in association with the PGFM pulses. Concentration of NOMs was greater (P < 0.05) at the peak of the PGFM pulse during early luteolysis (88.8 ± 15.0 μg/mL) than during late luteolysis (58.8 ± 9.0 μg/mL). Concentration of NOMs began to decrease (P < 0.05) 4 hours before the peak of the PGFM pulse of early luteolysis. Concentration began to increase (P < 0.05) an hour after the peak of the PGFM pulse of late luteolysis. An NOM decrease and increase was not detected during the PGFM pulse after luteolysis. On a temporal basis, results indicated that NO either is not required for luteolysis in mares or has a role in or responds only during late luteolysis. A caveat is that the relative contribution of the CL versus other body tissues to circulating concentrations of NOMs in mares has not been determined.
authors.affiliation: Eutheria Foundation, Cross Plains, Wisconsin, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA. Electronic address: ginther@vetmed.wisc.edu.
authors.forename: O J
authors.initials: OJ
authors.lastname: Ginther
authors.affiliation: Eutheria Foundation, Cross Plains, Wisconsin, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
authors.forename: C A
authors.initials: CA
authors.lastname: Wolf
authors.affiliation: Eutheria Foundation, Cross Plains, Wisconsin, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Baldrighi
authors.affiliation: Eutheria Foundation, Cross Plains, Wisconsin, USA; Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Greene
mesh_terms: D000818:Animals; D015237:Dinoprost / Q000031:analogs & derivatives / Q000097:blood*; D005260:Female; D006736:Horses / Q000097:blood*; D007986:Luteinizing Hormone / Q000097:blood; D003341:Luteolysis / Q000097:blood*; D009566:Nitrates / Q000097:blood; D009569:Nitric Oxide / Q000097:blood*; D009573:Nitrites / Q000097:blood; D010507:Periodicity; D011374:Progesterone / Q000097:blood
chemical_list: D009566:Nitrates; D009573:Nitrites; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D009569:Nitric Oxide; D011374:Progesterone; D007986:Luteinizing Hormone; D015237:Dinoprost
keywords: LH; Luteolysis; Nitric oxide; PGF2α; Progesterone